Teladoc Health Inc

Teladoc Health Inc(TDOC)の株式分析

$6.500

+0.143 (+2.20%)終値時点

Loading chart…
High
6.590
Open
6.400
VWAP
6.50
Vol
3.67M
Mkt Cap
1.72B
Low
6.395
Amount
23.83M
EV/EBITDA, TTM
5.94

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

AI analysis of Teladoc Health Inc (TDOC)

hold

Teladoc Health Inc is currently not a strong buy. The stock is trading at $6.50, with a forward P/E ratio of 303.03, indicating high valuation concerns. Additionally, the recent news of a 21% drop in share price due to a revenue miss and lowered guidance raises significant red flags. The company also faces a securities fraud investigation, which could further impact its stock price.

Analyst Ratings (13)

+37.08% upside
Buy
10 Buy
3 Hold
0 Sell
Current: 6.50
安値
7.50
平均
8.91
高値
12.00

Citi

2026-08-03

目標株価

$11

Hold

Jefferies

2026-07-30

目標株価

$8

Hold

Evercore ISI

2026-07-30

目標株価

$10

Hold

Citi

2026-07-23

目標株価

$11

Neutral

Canaccord

2026-07-21

目標株価

$11

Buy

バリュエーション指標

The current forward P/E ratio for Teladoc Health Inc (TDOC) is 303.03, compared to its 5-year average forward P/E of 22.59.

Forward P/E

Strongly Overvalued
5Y Average P/E
22.59
Current P/E
303.03
割高
135.07
割安
-89.88

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
16.76
Current EV/EBITDA
5.94
割高
33.44
割安
0.07

Forward P/S

Fair
5Y Average P/S
1.76
Current P/S
0.48
割高
3.87
割安
-0.34

Alphio AI Price Scenarios for TDOC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%TDOC

$7.29

シナリオ価格

B

Base

Base · 50%TDOC

$6.49

シナリオ価格

B

Bear

Bear · 25%TDOC

$6.11

シナリオ価格

Whales holding TDOC

V

Voss Capital, LP

+ HoldingTDOC

+0.55%

3M Return

TDOC FAQ — answered by Alphio AI

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Teladoc Health Inc is currently not a strong buy. The stock is trading at $6.50, with a forward P/E ratio of 303.03, indicating high valuation concerns. Additionally, the recent news of a 21% drop in share price due to a revenue miss and lowered guidance raises significant red flags. The company also faces a securities fraud investigation, which could further impact its stock price.

13 analysts cover TDOC: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 8.91.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める